Business Briefing | Legal News: Glaxo to Pay $45 Million to State Over Drug Marketing

GlaxoSmithKline agreed to pay Louisiana $45 million to settle lawsuits accusing it of improperly marketing the diabetes drug Avandia and other drugs.

    

No Responses to “Business Briefing | Legal News: Glaxo to Pay $45 Million to State Over Drug Marketing”

Post a Comment